Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
OPERATING EXPENSES
General and administrative (net of insurance reimbursement of $1,250,000 during the three months ended March 31, 2023 - See Note 5)	$ 1,689,182	$ 415,451
Research and development	1,613,275	1,235,614
Total operating expenses	3,302,457	1,651,065
Loss from operations	(3,302,457)	(1,651,065)
OTHER INCOME
Other income	82,033	130,531
Loss before income taxes	(3,220,424)	(1,520,534)
Income taxes
Net loss	$ (3,220,424)	$ (1,520,534)
Basic net loss per share (in Dollars per share)	$ (2.75)	$ (1.3)
Basic weighted average common stock outstanding (in Shares)	1,171,233	1,171,233